New HIV combo could free patients from daily pills

NCT ID NCT07054931

Recruiting now Disease control Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times

Summary

This study tests whether combining an HIV vaccine with powerful antibodies can help people with HIV control the virus without daily antiretroviral therapy. 48 adults with well-controlled HIV will receive the combination and briefly stop their regular medication to see if their immune system can keep the virus in check. The goal is to find a way to achieve long-term virus control, not a cure, as participants may still need monitoring or future treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV

Contacts and locations

Locations

Centre for Clinical Vaccinology and Tropical Medicine (CCVTM)
RECRUITING

Oxford, OX3 7LJ, United Kingdom
Guys and St Thomas' NHS Trust
RECRUITING

London, SE1 7EH, United Kingdom
St Mary's Clinical Trial Unit
RECRUITING

London, W2 1NY, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.